<DOC>
	<DOC>NCT03043612</DOC>
	<brief_summary>The purpose of this study is to evaluate the feasibility of the Cook Ureteral Stent to reduce post-stent placement pain and urinary symptoms in patients following ureteroscopy for urolithiasis.</brief_summary>
	<brief_title>Ureteral Stent Study</brief_title>
	<detailed_description />
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Patient is undergoing ureteroscopy for urolithiasis in which temporary ureteral stenting is indicated Patient is unwilling or unable to sign and date the informed consent Patient is unwilling to comply with the followup study schedule Patient is pregnant, breastfeeding, or planning to become pregnant during the course of the study Patient is currently taking anticholinergic or other antispasm medications Patient is currently taking sildenafil, tadalafil, or vardenafil Patient has a known sensitivity to alphablocker medications Patient is currently undergoing chemotherapy or radiation therapy Patient has an active urinary tract infection Patient is in chronic renal failure, on hemodialysis, or on chronic peritoneal dialysis Patient requires bilateral shock wave lithotripsy, bilateral stents, or has bilateral symptomatic kidney stones Patient has had a ureteral stent within the past three months in either ureter Patient is unable to accurately detect or report bladder function or pain Patient has chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Ureteroscopy for urolithiasis</keyword>
</DOC>